ARTL - Artelo shares jump after adding Tamara Seymour to its board of directors

Clinical stage biopharmaceutical company Artelo Biosciences (ARTL) shares rise nearly 22% premarket after announcing the appointment of Tamara Seymour to the company’s board of directors.Seymour is a corporate finance veteran with three decades of experience in the biotech and life sciences industries. She has served as chief financial officer in both public and venture-backed private companies at all stages of development.She has also raised over $250M in multiple private and public equity and debt financings, including spearheading an IPO.

For further details see:

Artelo shares jump after adding Tamara Seymour to its board of directors